text:
Minimum withdrawal at Dunder: £20
Maximum withdrawal at Dunder: £200 to £5,000, depending on the payment method
Visit Dunder and get 100% Bonus, up to £100 | T&C's Apply +18
Interesting articles for you:
Withdrawal fees: £2.50, except for Trustly which is Free of Charge
Cashout during weekends: Yes as long as the withdrawal is legal and within the terms and conditions.
Manual flushing: No
Cancel payment allowed: Yes
Withdrawal methods at Dunder: VISA, Neteller, Trustly, Skrill
Minimum deposit at Dunder: £20
Maximum deposit at Dunder: £200 to £5,000, depending on payment method
Deposit fees: 2.5% (VISA, MasterCard, Euteller); free of charge for the rest
Deposit methods at Dunder: Visa, Mastercard, Skrill, Neteller, Trustly, Paysafecard
Transaction times at Dunder:
Withdrawals with Dunder are usually processed within 24 hours. However, it will be longer depending on the payment method chosen. And if there is a need for additional verification, the withdrawal process will take longer.
Deposits at Dunder should be credited immediately – if not, contact customer support immediately to help locate the funds. Some bank accounts could take 2-7 days – depending on the country of origin.
Payout time depending on payment method:
- E-Wallet: withdrawal – immediate; deposit – immediate
- Debit cards: withdrawal – 1-3 business days; deposit – immediate
- Bank transfer: withdrawal – 1-3 business days; deposit – immediate
- Bank check: not offered
Currencies: British pounds sterling, Euros, Canadian dollars, New Zealand dollars, US dollars, Norwegian kroner, Swedish kronor
(Note that currency chosen for the account cannot be changed.)
Dunder is an online casino that is practically new in the industry. It was just launched in 2016. The online casino has thousands of games that players can enjoy. This gives them an opportunity to win big prizes – most of which they can withdraw into real money.
Of course, to be able to withdraw, players must deposit real money first. In order to do that, you have to create an account with Dunder Casino.
To do this, you have to go to the website and provide your email, password, and mobile number. Click on the "Continue" button after. You will then be taken to another form that will require you to provide your name, birthday, contact details (address, telephone number, and email address). It is important that you use your own name. This will be matched to the payment method that you will use. If the registered names differ, you will not be able to use it. Be careful about the information you will provide because you will only be allowed to create one account. In case a new account is required, the old one will have to be closed.
To complete the registration, you will be required to verify your identity. An email will be sent with instructions on how you can complete the verification process. This will involve several documents that will verify three things: your identity, residency, and your preferred payment method. Among the documents you will be required to submit will include a scanned ID, utility bill, and bank statement.
Once you have completed all of these, you can now start making financial transactions.
About withdrawal methods at Dunder
Before you deposit money, you have to know how you will withdraw funds first. After all, you wouldn't want to put money where you are not sure how to get it back.
Fortunately, you will not have any problems with getting your money from Dunder. You just have to make sure that you follow the instructions correctly and you have not violated any of the terms and conditions on the site. For instance, you need to wager a deposit at least once before you can withdraw it.
To make a withdrawal, you need to go to Your Account to access your finances. There, you will find the amount that you can withdraw. You can indicate the amount that you will withdraw and choose the payment method that you will use to get the money. Take note that you are required to use the same payment method that you used to make a deposit.
Withdrawals are usually processed within 24 hours after you have submitted your request. If you want to cancel, make sure it is at this time. After the money is processed, your money will register in your account depending on the processing time of the specific payment method that you have chosen. Usually, this takes 3 days. If the money is still not in your account within 72 hours after you received an email from Dunder, contact their customer support to help track where the money is.
There may be occasions when you will be required to submit additional verification. While it can delay the withdrawal process and it can admittedly be a hassle, this is for your own good. This is the way of the online casino to ensure that you are who you say you are. It is meant to protect your money from landing in the wrong account.
About making a deposit at Dunder
Now that you are certain that you can withdraw your money, you need to learn how to make a deposit. You cannot play and win real money unless you make a deposit first. Of course, you are allowed to play online casino games with Dunder but it will not give you the opportunity to win real prizes. That would not be as fun as it should if you know you can win and withdraw real money.
So how can you deposit money in your Dunder account?
Start by logging into your Account and clicking on the balance. This can be seen beside Deposit at the top bar. You have to choose your payment method – which will appear on the left side. You simply have to follow the instructions to complete the transaction. The payment method will vary depending on what country you are on.
In case you are having a hard time completing the transaction, that could mean there is a problem with the information you provided. You need to make sure the payment method you have chosen has the same name as the one registered in your Dunder account. Not only that, you have to consider the fact that your deposit method is usually the same one you will use when you make a withdrawal. So make your choice well.
The amount you deposited should be credited to your account immediately. If there is a problem, get in touch with the support team of Dunder. There are agents available 7 days a week to be of assistance. They are available from 11am to 11pm CET. You have the option to reach them through live chat or email.
All the information you will provide is kept safe by the state-of-the-art SSL encryption technology on every page of the Dender casino website. This will keep unauthorized individuals from accessing confidential information and using it maliciously.
Dunder FAQ
The currency options include Euros, British pounds sterling, US dollars, Canadian dollars, New Zealand dollars, Swedish kronor, and Norwegian kroner. You will be asked to choose your preferred currency when you create your account. You cannot change this anymore so make sure you choose correctly.
It is easy to withdraw from your Dunder account as long as you do not have pending wagering requirements to complete. You should also have completed the verification process. It is also required for you to wager a deposit at least once before it can be withdrawable.
To make a withdrawal request, you need to log in to your account first. Go to Your Account to look at your finances. Here you will see your payment method options. Choose your preferred option and follow the instructions as specified.
Dunder Casino can process withdrawals within 24 hours. After that, the processing time will depend on the payment method. The fastest is usually E-wallets that are immediately credited to your account. Credit and debit cards and bank transfers take 1 to 3 business days. The country where you are from can also have an effect on the processing time.
Check if you have met any wagering requirements – or maybe you encoded the wrong information. If none of these are in error, get in touch with customer support. You can opt to use the Live Chat feature. This is available 7 days a week from 11 am to 11 pm CET. You can also send an email but you may have to wait to get a response.


text:
Lucky Guy (Photos)
New York's real life lucky guy is back in a brand new play about his incredible and one of a kind career! Lucky Guy a play by the late Nora Ephron is making it's Broadway debut this spring with an incredible actor to recreate a one of a kind person. Tom Hanks headlines as Mike McAlary, the Pulitzer Prize winning reporter for the New York Post and Daily News. The new piece talks about McAlary's bright career in the dark 1980's New York atmosphere. Luner on Theatre brings you a first hand look today at Lucky Guy on Broadway!
Lucky Guy Officially opens on Broadway Tonight! The production is running at The Broadhurst Theater and is running as a limited engagement through June 30th only. Do not miss the chance to experience a true New York story and a legendary actor that comes along once in a generation. For more information, check out Lucky Guy's Official Broadway Website. Be sure to check Luner on Theatre on Facebook and Follow Us on Twitter as well! We are constantly updating these pages with information! And of course, check out the rest of Luner on Theatre for all your theatre news you don't only need but want to know and so much more!

subset: commoncrawl


text:
As the temperature increases, so do the number of insect bites.
Mosquitoes and other insects thrive in rising heat and humidity. East Texas has both. In a recent released report, the Centers for Disease Control and Prevention (CDC) found that Texas had the third highest quantity of mosquito-borne disease cases amongst all 50 states between 2004-2016.
Harmful diseases, such as Zika and Lyme, can travel through infected mosquito bites. Since 2004, nine new germs have been reported as spread by mosquito bites, two of these diseases being fatal.
The need for mosquito prevention and protection in our community is rising. The number of disease cases spread by mosquito, tick, and flea bites in the U.S. has tripled in the past decade. The Centers for Disease Control calls for local control organizations with greater tools and staff with greater expertise to effectively reduce the growing threat. These local control organizations are on the front lines of the battle against deadly diseases and are a valuable asset to the community.
Petty's Irrigation, Landscape, and Pest Control is a local control company that offers effective quality control of mosquitoes. With more than six decades of service to the community and a fully licensed staff by the Texas Department of Agriculture, Petty's Irrigation and Landscape is ready and qualified to address mosquito issues this season.
The CDC comments that many local control organizations lack the necessary tools to appropriately control mosquitoes. In contrast, Petty's is committed to staying up to date on the latest pest control practices through ongoing education. One of the ways they accomplish this is by utilizing cutting-edge technology and equipment.
Locals in the East Texas community have the opportunity to protect themselves from diseases this summer through Pest Control with Petty's. Get a free quote by calling 800-258-9184 or clicking the button below:


text:
Markets | NGI All News Access | NGI Data
Volatile Session Ends With Natural Gas Futures Up Penny; Cash Mostly Higher
Oppressive heat spanning most of the United States supported natural gas futures Monday, but cooler-trending long-range outlooks combined with another production record to send prices lower for most of the session. Most analysts considered $2.15 to be the battle line, and bulls came out victorious after a late technical rally lifted the September gas futures contract by a penny to $2.21/MMBtu, while October rose six-tenths of a cent to $2.213.
Spot gas prices were mostly higher as the sweltering summer heat was expected to reach as far north as Albany, NY. Fueled by stout increases in California and the Southwest, the NGI Spot Gas National Avg. rose 3.5 cents to $2.01.
The steamy conditions have have been at the forefront of the natural gas market over the last week, especially in Texas, where the state's grid operator set a fresh record for power usage on Aug. 12 and declared energy emergencies twice, all the while seeing power prices surge into the thousands. While the Lone Star State remains an oven, the dome of hot high pressure has extended into the northern United States, boosting temperatures to near the century mark in Washington, D.C. and Harrisburg, PA, as a line of storms bring additional humidity to the region, according to AccuWeather.
"The heat and high humidity will stick around through the middle of the week before a refreshing air mass moves into the Northeast on Thursday," AccuWeather meteorologist Courtney Spamer said.
It's this cooler air mass that is seen likely drenching demand in the upper regions of the country, but also sending temperatures back into the upper 80s and lower 90s in Texas through the end of the month. Genscape Inc. meteorologists are forecasting Lower 48 population-weighted cooling degree days (CDD) will drop from a peak of 145 on Tuesday to a low of 100 on Saturday. Only California and the Rockies are forecast to see hotter temperatures.
"As a result of the cooling, we are forecasting national demand during the next seven days will average 75.9 Bcf/d, about 2.44 Bcf/d lower than the previous seven-day average. We expect the daily numbers will top out at 80.1 Bcf/d Tuesday, then drop daily through Saturday," Genscape senior natural gas analyst Rick Margolin said.
Although the midday American model run was a touch hotter for next week, it trended even cooler for the tail end of August and early September, according to NatGasWeather. "The weather data would have needed to trend notably hotter for late this week through Sept. 3 to be considered bullish, and the weekend, overnight and most recent data failed to, giving weather sentiment a bearish bias after heat abates Wednesday into Thursday."
Nevertheless, the September contract hit its intraday low early in the session and then traded higher, although still in the red, for most of the day. In the last half hour, however, prices moved up another notch to finish slightly higher on the day.
Bespoke Weather Services said this final move higher occurred as news spread that Mexican exports may see a ramp up starting sometime next week.
Bulls have a lot working against them in their bid to stage a lasting rally, however. Sunday's production set another daily record high of 92.04 Bcf/d, according to Genscape. "This is the 10th time since July 1 that a new daily high has been established," Margolin said.
Monday's estimate was only slightly lower at 91.86 Bcf/d, but most weekday top-day estimates have been revised up in subsequent reporting cycles lately, according to Genscape. Including Monday's estimate, August month-to-date production is now averaging 91.28 Bcf/d, which is more than 0.85 Bcf/d above its forecast, according to Genscape.
"This exemplifies a theme we've been discussing frequently with clients of our production forecast lately: There are presently more upside risks to our near- and mid-term production forecasts than downside risks," Margolin said.
The dismal market outlook was reflected in the most recently available data from the Commodity Futures Trading Commission, which showed that money managers boosted their net short positions to more than 200,000 contracts, the most bearish data since 2015. While this would indicate there is limited "dry powder" in terms of selling interest, it is possible to see another probe lower at the front of the curve if fall weather ends up supporting bears' efforts to squeeze the last bit of profit out of an oversupplied market before attention turns to winter, according to Mobius Risk Group.
The shortest net position previously observed was in 1H2015 as the market came off a warmer-than-normal winter and, at the time, record production. This pushed prices to sub-$2 levels in early 2016, the Houston-based firm said. During the second half of 2016, however, there was a shift in oversupply, which quickly transitioned to undersupply as production growth slowed and liquefied natural gas (LNG) exports began.
"The next six to nine months are going to get another dose of LNG export growth and by winter, excess European natural gas stockpiles will be less of a headwind," Mobius said. "If the $2.00 barrier is to be tested again, it would likely require a string of triple-digit injections beginning in late September/early October."
Spot gas prices were mixed on Monday as prices in West Texas continued to crater, while some points in East Texas slipped a few notches despite the continued heat wave that resulted in about 85,000 customers losing power over the weekend.
Southwestern Electric Power Company (SWEPCO), which serves nearly 500,000 customers in Arkansas, Louisiana and a small portion of East Texas that is not covered by the Electric Reliability Council of Texas, had restored power to all but about 3,000 customers late Monday after extreme heat led to voltage problems on the company's transmission lines Sunday.
"We're methodically energizing our substations to ensure we can restore power to all customers tonight," said SWEPCO's Gary Guin, director of risk & reliability.
Houston Ship Channel next-day gas fell 2 cents to $2.075, while Waha plunged 37 cents to average 80.5 cents amid some pipeline maintenance in the nearby Midcontinent region and ongoing work on portions of the El Paso Natural Gas system.
Natural Gas Pipeline Company of America (NGPL) will cut throughput at its Compressor Station (CS) 107 in Mill County, IA by more than 700 MMcf/d beginning Tuesday and lasting through Saturday.
During similar work in the past, prices in the Midcontinent have fallen in order to compete with Permian Basin gas for space on the Amarillo mainline toward Chicago, according to Genscape.
Non-restricted flow through CS 107 has averaged 1,412 MMcf/d in the last 30 days.
"Prior events have seen Waha and El Paso Permian cash consistently undercut NGPL Midcon for the duration of these events," Genscape analyst Matthew McDowell said.
Meanwhile, downstream impacts have been buffered by an increase in receipts at interconnects with Trailblazer Pipeline in Nebraska, and Rockies Express Pipeline on the Gulf Coast mainline in Illinois. In past events, these two interconnects have matched the deficit created by restrictions in NGPL's supply zones, according to Genscape.
"During this event however, Trailblazer's interconnect with NGPL will be upstream of this constraint and unable to alleviate these supply issues," McDowell said.
Over in the steamy Southwest, prices were up in a big way. El Paso S. Mainline/N. Baja shot up 74.5 cents to $2.825, while SoCal Citygate in California jumped 77.5 cents to $3.00.
Most day/day price moves elsewhere across the country were limited to less than a dime, although a handful of Appalachia pricing hubs posted double-digit gains. Tennessee Zn 4 Marcellus shot up 33 cents to $1.64.
The Northeast also saw a few big movers. Both Transco Zone-NY and non-NY rose more than 20 cents to average $2.27 and $2.265, respectively.
© 2020 Natural Gas Intelligence. All rights reserved.


text:
Our client has a permanent full time vacancy for a Training Administration Assistant. You will be working 37 hours per week, 9am to 5.30pm, Mon to Thurs, 9am to 4.30pm Fri.
The Role
Work in the shared Training mailbox processing emails whilst adhering to set processes and procedures.
Training and Competency System database updating and maintenance.
Input new joiners' qualifications and training records.
Book courses.
Using the Training database
Liaising with training providers
Handling delegate queries
Ensuring attendance and feedback is monitored for all courses
Assist with Training Room diary management, including arranging refreshments and lunch vouchers or lunches as required.
Prepare Training Cabin rooms for training and meetings and clear away afterwards as required.
Create and enrol new users to the e-Learning portal.
Prepare and maintain directory of contacts for training services.
Maintain office supplies and assist with upkeep of printers and other office devices.
Any other ad-hoc administration support that may be required by the department.
Greet visitors to the training facility & provide refreshments as required.
Screen HR & Training Department incoming calls and direct or take messages as necessary.
Minimum 6 months experience in administration
Some experience of customer care
Working to deadlines whilst maintaining quality and high standards
Proven experience of working as part of a team
Capable of working with minimum supervision
Experience of working in a pressurised, demanding environment
Experience of Outlook, MS Word and Excel
Excellent organisation & planning skills
Excellent communication and interpersonal skills
Ability to apply a diverse range of communication techniques
Sound analytical and problem solving skills
Evidence of ability to effectively prioritise and manage work
Evidence of excellent presentation skills
Excellent Keyboard skills
Due to the large number of responses we receive it is not always possible to respond to every application. We will only contact those candidates short-listed for this role. If you have not heard from us within 7 days please assume you have been unsuccessful on this occasion. If you wish to apply for further roles please do so. We will retain your details on file and contact you should a suitable vacancy become available.


text:
This summer's music festival calendar is pretty crowded.
This weekend, there's not one, but three fests in the metro and a pricey new contender entering the fray next weekend.
Festivals have plenty of competition from the arenas, the State Fair Grandstand and the two big casinos (which have both upped their summertime outdoor concert game in recent years), not to mention the million other entertainment options for Minnesotans eager to make the most of their too-brief summer.
Already, there are some signs of concertgoer fatigue. The Vikings launched the three-day Summer Skolstice fest last month at its Eagan training facility with three theater-level headliners (Rick Springfield, Elle King, St. Paul and the Broken Bones) that drew theater-sized crowds. And Rock the Garden – which has sold out instantly in previous years – still had tickets available the day of the show.
Here's a look at the next four fests:
Basilica Block Party
- What: Now in its 25th year, the Basilica Block Party stands as one of summer's biggest musical events in the Twin Cities and typically draws more than 25,000 fans. Sponsored by Cities 97, it's a fundraiser to help pay for structural restoration of the Basilica of St. Mary.
- When: 5 p.m. Friday and Saturday.
- Where: The Basilica of St. Mary, 88 17th St. N., Mpls.
- Lineup: Album of the year Grammy winner Kacey Musgraves headlines the main stage on Friday with support from Dawes, Anderson East and Ruston Kelly. The second stage features Semisonic, the Jayhawks and Yam Haus, while the third offers Kiss the Tiger, Annie Mack and McNasty Brass Band. "I'm Yours" hitmaker Jason Mraz wraps things up Saturday with help from Hanson, Johnnyswim and Lissie. Stage two features Chvrches, Metric and Flora Cash, while Static Panic, the Bad Man and Michael Shynes play the third stage.
- Tickets: All the VIP options are sold out. Single day general admission is $70 or $125 for both. There's also a package deal for $308 that includes four tickets and vouchers for four Bud Lights.
- More information: basilicablockparty.org.
Lakefront Music Fest
- What: For 10 years, the Lakefront Music Fest has offered two nights of live music – one country, one rock 'n' roll – for a terrific price. The Prior Lake Rotary Club presents the festival with the Shakopee Mdewakanton Sioux Community and Mystic Lake Casino as partners. Ticket sales benefit several local nonprofits including the YMCA of the Greater Twin Cities.
- When: 5 p.m. Friday and Saturday.
- Where: Lakefront Park, 5000 Kop Parkway, Prior Lake.
- Lineup: The Steve Miller Band tops Friday's bill, which also includes Joan Jett and the Blackhearts, Marty Stuart and His Fabulous Superlatives (not rock, but whatever) and Matt Andersen. Country star Brad Paisley closes out Saturday with help from Chris Lane and Riley Green.
- Tickets: Prices started at $35 a night or $50 for both, but have gone up as the festival approaches. VIP options are sold out, leaving only single-night, $45 general admission tickets. They won't be sold at the gate, either, and must be purchased online.
- More information: lakefrontmusicfest.com.
Buck Concert Series
- What: The Buck Hill resort in Burnsville offers skiing and snowboarding in the winter, tubing and mountain biking in the warmer months and this three-day outdoor classic rock festival.
- When: 4 p.m. Friday and Saturday.
- Where: Buck Hill, 15400 Buck Hill Rd., Burnsville.
- Lineup: The festival started Thursday with Lou Gramm, the original lead singer of Foreigner, Asia and the Def Leppard tribute band Def Leggend. Former Eagles guitarist Don Felder headlines Friday with support from John Waite and Them Pesky Kids. The Guess Who, Foghat and Heart tribute band Heartless wrap things up on Saturday.
- Tickets: VIP tickets, which include indoor access, are $99 per night. General admission is $35, or $40 for early entry.
- More information: buckhill.com.
Twin Cities Summer Jam
- What: KFAN DJ and musician Chris Hawkey and the promoter of Brainerd's Lakes Jam cooked up the idea for this ambitious new festival, which offers seemingly unlikely pairings of rock and country acts and a $4 million pricetag. (Multi-platinum country duo Florida Georgia Line ran with that idea at Target Field in 2017 and invited grown-up boy band the Backstreet Boys and rapper Nelly to open.) Tim McGraw is a partner for the fest and is also a headliner with his own hand-picked opener, rapper Pitbull.
- When: 2 p.m. July 18, 1 p.m. July 19-20.
- Where: Canterbury Park Festival Field, 1100 Canterbury Park, Shakopee.
- Lineup: Country trio Rascal Flatts and classic rockers REO Speedwagon kick things off July 18 with locals Soul Asylum and Quietdrive. Aerosmith take a break from their Las Vegas residency to headline July 19 with Buckcherry, Chris Hawkey and Elvie Shane. The aforementioned pairing of Tim McGraw and Pitbull close out the festival July 20 with Hobo Johnson and the Lovemakers and Christina Taylor.
- Tickets: Hold on to your cowboy hat, they're asking a lot. General admission is $149 per night or $249 for all three. Amazingly enough, the $1,200 VIP three-day tickets are sold out, with $900, $800, $600 and $400 options still available. There's also a special area in front of the stage that's accessible only to fans who pay $150 per night on top of the tickets they're already purchased. (Unsurprisingly, organizers have been selling discounted tickets via Groupon.)
- More information: tcsummerjam.com.


text: The Prince has been turned into a silly-looking loud-mouthed beast because of his selfish and unruly behavior. In order to break the spell he must learn to be well-mannered, sincere, gracious and pure of heart. But most importantly, he must find someone to love him for who he is, both inside and out. Will Beauty fall in love with the Prince or will his comical looks and beastly behavior scare her away?


text:
Don't feel like packing up your home to move again? Need someone to move your small business across Florida or the United States? Chosen One Movers LLC is a trusted residential and commercial moving company based in Gulf Breeze, Florida, serving all of the panhandle. For years, our movers have offered high-quality packing, delivery and local moving services to get our customers from point A to point B without a hitch. Find out what we can do for you - call our movers in Gulf Breeze & Pensacola and surrounding areas in Florida today for assistance in your move whether it's within Florida or across the country!
Moving might be a stressful time, but Chosen One Movers will make sure your day is a breeze! Whether you're moving out of your home or out of your office, you can trust our moving company based in Gulf Breeze and serving anyone in the panhandle for assistance in moving anywhere in the US! Get a free quote from our team today.
Our services include:
local moving services | residential moving service | commercial moving company
packing service | unpacking service | delivery service | moving services | large item moving
Gulf Breeze, FL 32563GET DIRECTIONS
Call Us
Primary: (850) 368-6209
Evenings: (850) 485-2794
Mon: 7:00AM-5:00PM
Tue: 7:00AM-5:00PM
Wed: 7:00AM-5:00PM
Thu: 7:00AM-5:00PM
Fri: 7:00AM-5:00PM
Sat: 8:00AM-4:00PM
Sun: Closed


text:
Kony 2012
Originally posted by keiramarcos at Kony 2012
Originally posted by romennim at we won't back down
Originally posted by princess_aleera at we won't back down
Originally posted by synnerxx at we won't back down
Spread the word. Link to this post if you want. I have it unlocked so everyone can see it. Do everything in your power to get the word out and make this known to everyone.
Spread the word. Link to this post if you want. I have it unlocked so everyone can see it. Do everything in your power to get the word out and make this known to everyone.
GET INVOLVED. STOP AT NOTHING. THE WORLD MUST KNOW.In the words of Keira: NOTE: THIS ORGANIZATIONS POLITICS AREN'T IMPORTANT TO ME. [....] I DIDN'T KNOW WHO JOSEPH KONY WAS. TODAY I DO. I THINK EVERYONE SHOULD KNOW WHO THIS MAN IS AND WHAT HE'S DONE. THAT'S WHY I POSTED THIS VIDEO.
I dare you to stop scrolling through your dashboard. Stop checking your Facebook newsfeed that you've already checked two seconds ago. Stop updating your Twitter and seeing what your favorite celebrities are saying. Stop watching funny and nonsense videos on Youtube. Take time to educate yourself to MAKE A DIFFERENCE in this world. This is your chance! WATCH THIS VIDEO.
Let's make JOSEPH KONY Famous!!
Who is JOSEPH KONY?
He is THE WORST LIVING CRIMINAL. He abducts children and makes them use guns to kill their own parents. He takes girls and forces them to be sex slaves. He calls his abducted children the Lord's Resistance Army, AKA the LRA. He has abducted over 30,000 children and forced them to be child soldiers in Central Africa. He remains at large because he is INVISIBLE to the world. FEW know his name, even FEWER know his crimes. WE ARE MAKING HIM FAMOUS! Because when he is, the world will unite against him and demand his arrest.
We can help make a change. We can make a difference.
I feel so inspired. I feel the need to help and make a difference. This has to happen in 2012. We can't let him go around and keep doing this to children in Central Africa. Let's make his name known so he can be stopped. HE CAN NO LONGER BE INVISIBLE!


text:
B.A. in Leadership Studies
Complete your bachelor's degree at Otterbein. Make an easy transition from a two-year to a four-year degree by completing your bachelor's degree at Otterbein. Liberal Studies in Leadership, our degree completion major, is uniquely designed for adult students who have already completed 64 semester hours (or 90 quarter hours) of transferable credit.
See our course catalog for more information about program courses and requirements.
You'll learn to integrate the skills, knowledge, and values of a broad academic program and apply them to the challenges of the workplace. Then advance your career by applying a range of perspectives and decision-making models. Students have discovered that success in the workplace and in their personal lives depends on the ability to create and apply solutions based on thinking across academic disciplines.
Take the next step. To meet with an advisor, contact Adult and Transfer Admission at 614.823.1356, or email@example.com, or visit Adult Admission.


text:
Ben Berggreen – US Futures Primer
Ben Berggreen has been a Professional Trader for over 20 years and has had incredible success managing some of the largest trading desks at Hedge Funds globally since the 1990's.
Ben was part of the trading team at Franklin Templeton in the U.S. working on the European Equity Value portfolios team, which was responsible for $850bln of Assets Under Management (AUM). Ben then worked as a Quant Trader managing the desk at Pacific Investments in London and then moved to Nuveen Investments in Chicago covering Asian Equities. He finished up trading as a Hedge Fund Manager at Nuveen in California. In Retirement, Ben still consults to Hedge Funds globally on a part time basis and is a Professional Futures trader, managing his own and a small group of investors' money in Los Angeles.
In this Video, Ben takes viewers a journey of how to understand the Futures Markets properly and how Professional Traders like himself go about trading Futures every day. In this Video lesson Ben deconstructs Futures contracts, how they work, how to calculate risk and opportunity, how to trade on Margin and how to maximize opportunities from big moves over the short term in various Futures Markets. This Video Lesson is a valuable resource for anyone who is interested in learning how to trade Futures Contracts in the U.S. over the short term on Margin in Indices, Currencies and Commodities.


text:
Macro Millionaire And The Seven Summits Trader
Test drive the Macro Millionaire Coaching Program RISK FREE for 90 days. Meet the Seven Summits Trader Mark Soberman. Learn Forex Live from Hector DeVille. John Thomas, the mad hedge fund trader: "I just issued my #1 trade to make right now…But you're NOT on the list to get it!" You already know there are only three to five "big trades" a year you absolutely must catch. This trade is one of them.
If you don't do something to get on board this trade ride now, you'll be kicking yourself when you read in the Wall Street Journal about how much money it made us. By then, it will be far too late to make any money with it. I'm betting this baby doubles our money. I'd love to send it to you, but first you need to accept your 100% RISK FREE 90-Day Test-Drive of Macro Millionaire.
"You can TEST-DRIVE Macro Millionaire for a FULL 90 days RISK FREE BEFORE making your final decision"
You read that right. You don't need to make a final decision today about joining Macro Millionaire. You can just test-drive and experience the program for yourself. Let me coach you for 3 months, risk-free. Follow my trades as I make them live in the market. I'll let you follow the trades I make in my elite hedge fund. Many wealthy, savvy and very connected investors invest a minimum of $5 million to get into my fund, and pay me at least $100,000 a year to make these trades for them – but in Macro Millionaire, you can trade alongside me.
Let me spend 90 days transforming you into a world class trader who finally makes real money – no matter what the market is doing – BEFORE you decide if it's right for you. If you think there is even the slightest chance you'd be better off financially if you have a top performing hedge fund manager, mentor and coach to trade alongside, then pull the trigger and take this risk-free, 90-day test-drive.
Mark Soberman: I'm announcing this big decision on TOMORROW's Live Q&A Session starting at 12pm Noon Eastern (New York Time). If you don't already have your logins because you originally thought the Seven Summits Trader was 'out of reach', you gotta get them now because I'm doing this especially for you. Can't wait to share the news with you!
As I mentioned yesterday, because of Alex's email, I decided to do whatever I could to share the Seven Summits Trader with as many people as possible… and give them a chance to actually *use* the SST while they make smaller, more manageable payments.
Introducing: the $297 down, $297 a month for 6 months SST Payment Plan! Sounds just like it is. Just pay $297 today to take home the Seven Summits Trader full-version. You get the software, the course, the training, the Owner's Club, the live training rooms and support… for $297 to start.
If the Seven Summits does not make you money in 45 days, just return it like you would under the regular 45-day Performance Guarantee and we'll give you a full refund. BUT! If the SST *does* make you money and you find yourself as hooked as we are – do nothing and continue making small payments of $297 a month for the next 6 months.
General consensus has been that the SST 'ramp-up' is QUICK so you could be done with your payments much sooner than 6 months… it's all up to you! This system is designed for maximum results with minimum time commitment, so if you're looking for a flexible way to supplement your income (like Alex), don't be afraid to take the next step… I've made the price a 'non-issue' for you :)
This is a special offer that has a limited shelf-life (obviously, I can't afford to do this for long). Get yourself pumped and get going right here: Coach TJ just told me the INCLUDED trading room is packed… which means we'll have to wrap-up this release in the next 24 hours. If you're interested, don't wait (you're going to kick yourself if you do!):


text:
FLYOVER ALERT: Food City 500 (Bristol Motor Speedway) – April 17th, 2016
AirshowStuff has learned that two A-10 Warthogs from Moody AFB in Georgia will flyover the Food City 500 this Sunday at Bristol Motor Speedway! The race can be seen on your local FOX affiliate. The flyover is expected around 1pm Eastern. If you live in North Eastern Tennessee, you may get a glimpse of the… Read more


text:
American Airlines' chief executive said on Thursday he is not "particularly excited" about Qatar Airways' interest in buying up to 10% of the US carrier's shares, in a letter to employees following the state-owned Persian Gulf airline's overture.
The move by Qatar Airways would expand its investments in North America as Qatar is embroiled in the region's worst diplomatic crisis in years and is locked in an airspace rights row with three other Middle East states, Reuters reported.
Separately, American Airlines Group Inc is already part of a push by US carriers to squeeze Qatar out of their domestic market.
Along with United Continental Holdings Inc and Delta Air Lines, American has pressed the US government to curb US flights by Qatar Airways and rival Persian Gulf carriers Emirates and Etihad Airways.
The US carriers charge that their Persian Gulf rivals have received billions of dollars in unfair state subsidies, allegations the Persian Gulf carriers deny.
In his letter, American CEO Doug Parker promised to continue American's "full court press ... to stand up to companies that are illegally subsidized by their governments".
He also said he found Qatar Airways' proposed investment "puzzling given our extremely public stance on the illegal subsidies that Qatar, Emirates and Etihad have all received over the years from their governments".
Qatar Airways responded on Twitter, saying: "We are glad to see American Airlines' CEO Doug Parker's perspective that he agrees with Qatar Airways' belief that American Airlines is a solid financial investment."
Shares of American Airlines rose more than 5% in pre-market trade after it disclosed the potential investment. The stock closed up 1.1%.
Qatar Airways said in a statement that it sees a "strong investment opportunity" in American and that it "intends to build a passive position in the company with no involvement in management, operations or governance".
"Qatar Airways plans to make an initial investment of up to 4.75%. Qatar Airways will not exceed 4.75% without prior consent of the American Airlines board. Qatar Airways will make all necessary regulatory filings at the appropriate time," it added.
American, in its filing, noted potential obstacles to Qatar's plan, as its rules prohibit "anyone from acquiring 4.75% or more of the company's outstanding stock without advance approval from the board". It said it had received no request from Qatar for such approval. Further, American said, "there are foreign ownership laws that limit the total percentage of foreign voting interest to 24.9%".


text:
A teen was arrested Thursday after threatening a "Round 2" of the massacre in a Florida high school that killed 17 people.
The threat that the teen made was posted on Snapchat, where he uploaded a photo of himself wearing a partial mask and holding an assault rifle. The photo included a caption that read, "Round 2 of Florida tomorrow." The teen has been arrested and was charged with disturbing schools and is now awaiting arraignment.
The post was made by a ninth-grader from Spartanburg South Carolina just one day after the deadly shooting at Marjory Stoneman Douglas High School in Parkland, Florida, where a 19-year-old gunman armed with a semi-automatic rifle opened fire on the school, killing 17 people.
School officials at Broome High School were alerted to the threatening Snapchat post by the unidentified teen's classmate. Police were able to identify the teen and visit his home. At his home the mask featured in the photo, as well as the rifle, which turned out to be a pellet gun. The teenager told authorities that the post was meant to be a joke.
The Broward County Sheriff's Office released a statement saying it has investigated the source of the post, which has been circulating in social media.
"Variations of the post have continued to be circulated over social media with captions added to warn people not to go to various schools throughout South Florida," said the department. "The post being circulated are being monitored for any violations of law or threats to public safety. Should any violations of laws or threats to the public be found, the poster will be prosecuted to the fullest extent of the law."
Authorities also warned the public of any would-be copycats, saying that any post that appears to be threatening in nature should be brought to the attention of law enforcement so they could be validated.


text:
DevTeam.Space is an AI-powered community of expert development teams where businesses can hire and effortlessly manage top-level developers. Our mission is to help more businesses to build great online products.
Over the past 3 years, more than 100 businesses including Airbus, NEC, Carvana, Poynt, and startups from YCombinator and 500Startups have used our services. You can see some of the featured projects here.
1 200 top developers
over the last 3 years
process to guide you to success
Building a great online product in today's world requires a team of expert developers and a well-organized product development process. Only by handling both correctly is it possible to build successful apps and software products.
That is why we have built an invite-only community of expert development teams, where each development team has extensive expertise in a particular tech stack or product type. Thus, businesses can hire and work with expert developers, not freelancers.
To maximize our clients' success, we've engineered a unique AI-powered agile process. It includes a set of tools for better communication, notifications, performance tracking, and payments. All of our vetted developers are trained to follow this process.
This helps our clients to build exceptional online products.
Core team
Headquartered in Los Angeles California, DevTeam.Space is a passionate team of tech innovators, product managers, and engineers.
Staying true to our mission, we use our own services to continuously build the DevTeam.Space platform. This is the secret recipe behind our fast growth and is why we are so confident in the unique benefits that our solution can bring to businesses around the world.
Excited to join the team and innovate with us? Drop us a line at [email protected]


text:
Find some helpful smart gadgets to make their life easier. In this page, you can find all the essential gadgets that will be worth your money spend.
Though you may find it strange that in the year 2019, is there still anyone who has not used any technology or gadget? As the smartphone has become so common and is used by everyone whether a small kid to young adult. But still, are you making the full use of the technology? Can you use the smartphone and all its features!? Many will nod in agreement but many are still there who may not be aware of all a smartphone or multiple gadgets features but still, they own it!
If you belong to the latter category then you must clear your basic concept first and learn what are the most important gadgets and which gadget can actually ease your life!?
Look below some handful of "essential" technologies that are a must invest by everyone, whether you are new to technology or not! These handy smart gadgets below can really make your life easier in multiple different ways.
A Good Branded Smartphone
As there are so many smartphones available in the market, it is essential to invest only in a good model that runs for years. A local Chinese model phone might run for a few months and then end up after a few usages. You can find some great smartphones from Poundit and use the unique Poundit promo code to get the budget-friendly smartphone.
A Computer for your needs
Initially, the computers started off as a large machine, as big as appliances like refrigerators or washing machine. But now the new generation of computers is so handy that it can easily adjust in your bags like a clamshell and curve and twist easily in every direction. There is a wide range of laptops available offering everything based on your need.
A Smart Speaker
A smart speaker is the easiest device to use, just by the saying of your words. There are multiple smart speakers available from Google Home to Amazon Echo Dot. You can invest in any of them and easily shop it from Lazada by just using Lazada promo code and get the speaker at a discounted price.
A Streaming TV Device
A streaming device allows you to watch television and shows just when you want. Whether you want to watch Netflix or Hulu, a streaming device will help you access tv shows and along with it you can also enjoy games, check online stores and lots more. Basically everything and more what you do in a smartphone.
A Smartwatch
A Smartwatch is one most important tech gadget that you may need in order to stay healthy and stay notified of any message instantly on your wrist. How? The smartwatch records heart rate, count the steps you have taken, sleep rate and much more. Basically, it offers everything that let you know about your health at the right time and so that you can work on it. You can also buy yourself a good smartwatch-like Ticwatch using Ticwatch promo code. A ticwatch works on an android phone and the cool design lets you stay stylish on the go.
So, without thinking any further, invest your money in the above smart gadgets and make your life easier with these technologies.


text:
The caspofungin clinical trial database offers an opportunity to assess susceptibility results for Candida pathogens obtained from patients with candidiasis and allows for correlations between efficacy outcomes and MICs. Candida isolates have been identified from patients enrolled in four studies of esophageal candidiasis and two studies of invasive candidiasis. The MICs of caspofungin for all baseline isolates were measured at a central laboratory using NCCLS criteria (document M-27A); MICs for caspofungin were defined as the lowest concentration inhibiting prominent growth at 24 h. MICs were then compared to clinical and microbiological outcomes across the two diseases. Susceptibility testing for caspofungin was performed on 515 unique baseline isolates of Candida spp. obtained from patients with esophageal candidiasis. MICs for caspofungin ranged from 0.008 to 4 μg/ml; the MIC50 and MIC90 were 0.5 and 1.0 μg/ml, respectively. Susceptibility testing was also performed on 231 unique baseline isolates of Candida spp. from patients with invasive candidiasis. The majority (∼96%) of MICs were between 0.125 and 2 μg/ml, with MIC50 and MIC90 for caspofungin being 0.5 and 2.0 μg/ml, respectively. Overall, caspofungin demonstrated potent in vitro activity against clinical isolates of Candida species. A relationship between MIC for caspofungin and treatment outcome was not seen for patients with either esophageal candidiasis or invasive candidiasis. Patients with isolates for which the MICs were highest (>2 μg/ml) had better outcomes than patients with isolates for which the MICs were lower (<1 μg/ml). Additionally, no correlation between MIC and outcome was identified for specific Candida species.
Caspofungin is a parenteral echinocandin antifungal with known fungicidal activity against Candida species (1, 2, 5, 8, 9). As caspofungin specifically targets the fungal cell wall as opposed to the fungal cell membrane, this echinocandin retains activity against clinical Candida isolates with documented resistance to either the azoles or the polyenes (4, 14, 17, 29). In several phase II/III trials, caspofungin has exhibited efficacy outcomes comparable to those of amphotericin B deoxycholate or fluconazole for the treatment of esophageal candidiasis (3, 30, 31). Similarly, in a large multicenter study, caspofungin was as effective as amphotericin B deoxycholate in the primary treatment of invasive candidiasis (candidemia and other Candida infections) (12, 15). In all of these studies, caspofungin has demonstrated an excellent safety profile with few serious drug-related adverse events and few therapy discontinuations resulting from toxicity (3, 12, 15, 30, 31).
Despite its favorable clinical profile against Candida infections, the utility of in vitro susceptibility testing for caspofungin has not been fully established. Recent work has focused on the development of a standard, reproducible method of susceptibility testing for caspofungin. This study, involving 17 different microbiology laboratories, assessed the interlaboratory reproducibility of caspofungin microdilution susceptibility testing against a panel of 30 isolates of various Candida species. Consistent MIC data were obtained using the broth microdilution method (M-27A) set forth by the National Committee for Clinical Laboratory Standards (NCCLS); the greatest reproducibility was generated with the visual "prominent growth reduction" endpoint (MIC2) measured at 24 h in RPMI-1640 medium (18). Surveillance studies employing this method have demonstrated excellent in vitro potency and a wide spectrum of caspofungin activity against a variety of clinical isolates of Candida species (20-22).
The caspofungin clinical trial database provides an additional opportunity to assess in vitro susceptibility results for caspofungin against Candida isolates. All Candida isolates collected from patients enrolled in the caspofungin studies involving either esophageal candidiasis or invasive candidiasis were evaluated by using the susceptibility endpoint that equates to a prominent inhibition of growth. Herein we describe the MIC results for caspofungin against all unique baseline isolates from these studies. The following report also provides correlations of MIC data to efficacy outcomes for the indications of esophageal candidiasis and invasive candidiasis in an attempt to identify caspofungin susceptibility breakpoints for Candida spp.
Overview of clinical studies of esophageal candidiasis. (i) Description of studies.Four phase II and III studies have evaluated the efficacy of caspofungin against esophageal candidiasis, including three phase II studies (protocols 003, 004, and 007) and a pivotal phase III study (protocol 020). The first two phase II trials (protocols 003 and 004) were randomized, double-blind studies comparing various doses of caspofungin (35, 50, or 70 mg/day) to intravenous amphotericin B deoxycholate (0.5 mg/kg of body weight/day) (3, 30). The third phase II study (protocol 007) was a small, noncomparative study primarily performed to evaluate the pharmacokinetics and efficacy of caspofungin for patients with esophageal candidiasis. The pivotal phase III study (protocol 020) was a double-blind (with in-house blinding), randomized trial which compared caspofungin (50 mg/day intravenously) to intravenous fluconazole (200 mg/day) for the treatment of documented esophageal candidiasis (31). Overall, a total of 236 patients with documented esophageal candidiasis received caspofungin in these four studies.
All four studies of esophageal candidiasis shared common design elements. In each of these four studies, patients had to be at least 18 years of age with symptoms and microbiological documentation of esophageal candidiasis. At study entry, patients underwent esophageal endoscopy, with photographic documentation and biopsy, as symptoms and/or protocol dictated. In all studies, specimens from brushings and biopsies were collected for culturing and subsequent susceptibility testing. Severity of disease was graded according to a four-point scale for patients with esophageal candidiasis, as per prior studies (10-12).
(ii) Efficacy assessment.In all four esophageal candidiasis studies, the primary clinical endpoint was the combined evaluation of symptoms and endoscopic lesions. A favorable clinical response required the complete resolution of symptoms and a substantial reduction in the number of endoscopic lesions. For all four studies, an endoscopy was performed at an early follow-up visit for all patients. A favorable microbiological response, defined as eradication (no Candida isolated on culture) or presumptive eradication (no culture performed because no visible lesions were identified on the follow-up endoscopy), was considered a secondary efficacy endpoint, because the eradication of Candida species is difficult to achieve in such severely immunocompromised patients.
Overview of clinical studies of invasive candidiasis. (i) Description of studies.Two separate studies have evaluated the efficacy of caspofungin in the treatment of documented invasive Candida infections. The pivotal study (protocol 014) was a randomized, double-blind (with in-house blinding), comparative study for patients with documented invasive Candida infections (15). In this study, patients with clinical and microbiological evidence of invasive candidiasis received caspofungin (50 mg daily, following a 70-mg loading dose on day 1) or amphotericin B deoxycholate (0.5 to 1.0 mg/kg daily). A second study (protocol 026) also included a limited number of patients with invasive Candida infections at study entry (32). This empirical therapy study (protocol 026) was a double-blind (with in-house blinding), randomized, comparative study to evaluate the safety, tolerability, and efficacy of caspofungin (50 mg/day following a 70-mg loading dose) versus liposomal amphotericin B (3 mg/kg/day; AmBisome) in the treatment of presumed fungal infections in patients with persistent fever and neutropenia. Of the 1,111 patients enrolled in this study, a total of 24 patients had invasive candidiasis (12 in each treatment group) at study entry. Across these two studies, a total of 127 patients received caspofungin for documented invasive candidiasis.
The two studies shared certain common elements with regard to the patients enrolled with invasive candidiasis. In both studies, all patients had clinical and microbiological evidence at study entry. For patients with candidemia, blood cultures were collected daily until cultures were negative for Candida for up to 48 h. Similarly, based on the site of the underlying infection, follow-up cultures and/or radiographic studies were collected at these otherwise sterile sites of infection to confirm eradication and radiographic resolution, respectively.
(ii) Efficacy assessment.The primary efficacy parameter for the patients with invasive Candida infections in each of the two studies (protocols 014 and 026) was the overall response. A favorable overall response necessitated that the patient have a favorable clinical response and a favorable microbiological response at the end of study therapy. The two studies implemented very similar definitions of a favorable overall response. Slight differences were noted in the definition of a favorable clinical response. Whereas a favorable clinical response in the study of invasive candidiasis (protocol 014) required the resolution of all signs and symptoms related to Candida infection, a favorable clinical response in the subset of patients with invasive candidiasis enrolled in the empirical therapy study (protocol 026) included all patients who had resolution or clinically meaningful improvement in all attributable signs and symptoms.
The microbiological outcome was a component of the overall response. In both studies, a favorable microbiological response was limited to eradication or presumptive eradication. Eradication signified cultures negative for Candida spp. at the end of study therapy or demonstrated at a prior on-therapy time point with no clinical evidence of infection. Infections that required an invasive procedure for the documentation of negative cultures were considered to have an evaluation of presumptive eradication if there was no apparent evidence of residual infection from symptoms, physical examination, or appropriate noninvasive studies. Note that the classification of presumptive eradication was limited to patients with nonblood sites of infection.
Overview of efficacy analyses.In the studies of both esophageal candidiasis and invasive candidiasis, efficacy results were analyzed using a modified-intention-to-treat (MITT) approach and an evaluable-patients (EP) approach. The MITT population, which was the primary subject of analysis, included all randomized patients who met the definition of documented Candida infection and received at least one dose of caspofungin therapy. The EP analysis included all randomized patients who met the MITT criteria, received at least 5 days of caspofungin study therapy, and had appropriate end-of-therapy evaluations.
Isolates and antifungal susceptibility testing.At study entry, specimens were collected for the culturing of Candida species during endoscopy (for esophageal candidiasis) or from the sterile site of infection (for invasive candidiasis). CHROMagar (Paris, France) and differential medium were provided to all sites to assist in the preliminary isolation and identification of Candida spp. Subcultures of stock cultures were prepared on Sabouraud dextrose agar slants and sent at appropriate intervals to the Merck Clinical Microbiology Laboratory (Rahway, NJ) for definitive identification and antifungal susceptibility testing. At Merck, all Candida isolates were identified to the species level by a combination of the Dade MicroScan Rapid Yeast Identification assay (West Sacramento, CA), conventional microscopy, and culturing on CHROMagar (Paris, France). Broth microdilution MICs for caspofungin were determined by using the NCCLS M-27A methodology (16). Assays were performed using buffered RPMI 1640 medium, inocula of 103 CFU/ml, and an incubation temperature of 35°C for 24 h. For Candida isolates, the MICs for caspofungin were defined as the visual endpoint that equates to prominent inhibition of growth (18).
Following identification and susceptibility testing, a unique baseline isolate(s) from each patient was identified in an effort to allow for these assessments of outcomes per pathogen and per MIC. The unique baseline isolate(s) for each patient consisted of only the isolate(s) obtained on the date closest to the initiation of study therapy; on that day, only one isolate from each identified Candida species was included, unless the multiple isolates from the same Candida species had widely differing MIC findings (>2-fold difference in MICs collected from the RPMI 1640 medium). If the patient had multiple sterile sites of infection at study entry (i.e., blood and peritoneal infection), only one of the samples was included in the unique baseline isolates, unless the species differed or MICs at the two sites were widely different.
Where possible, the Candida isolates from the site of infection were also collected from those patients with unfavorable microbiological responses to caspofungin. Coupled with the unique baseline isolates, such subsequent isolates were used to ascertain whether an increase in MIC for the Candida isolate following caspofungin therapy may have correlated with the eventual failure.
Esophageal candidiasis. (i) MIC distribution.Susceptibility testing for caspofungin was performed on 515 unique baseline isolates from all patients enrolled in the four phase II or III studies of esophageal candidiasis (Fig. 1). Of the 515 isolates, 292 were obtained from patients who were subsequently treated with caspofungin. The distribution of MIC results for caspofungin among these 292 isolates is generally consistent with the pattern for all isolates (Fig. 1). Overall, MICs for caspofungin ranged from 0.008 to 4 μg/ml, with a majority (∼95%) of values between 0.25 and 2 μg/ml. In fact, the MIC50 and MIC90 for caspofungin across all Candida species was 0.5 and 1.0 μg/ml, respectively (Table 1).
(ii) Correlation of MIC to outcome.The correlation of caspofungin MICs to clinical outcomes for the patients with esophageal candidiasis is shown for the MITT population and the EP population in Fig. 2A and B, respectively. For both efficacy populations, there was no clear correlation between MIC for caspofungin and therapeutic outcome for caspofungin-treated patients. Notably, patients with isolates for which MICs were higher (1 to 2 μg/ml) tended to have better outcomes than patients with isolates for which MICs were lower (<0.5 μg/ml). Similar trends were noted among the four specific studies (protocols 003, 004, 007, and 020) and across the three specific caspofungin doses (35, 50, and 70 mg/day). Similar patterns were also noted in the relationship of MICs for caspofungin to microbiological outcomes (data not shown).
C. albicans was the sole pathogen identified in most patients (>150) with esophageal candidiasis. Approximately 44 patients had mixed infections with C. albicans and a non-C. albicans Candida species (including, in descending order, C. glabrata, C. guilliermondii, C. krusei, C. tropicalis, and C. parapsilosis). As C. albicans likely represents the predominant cause of the infection for patients with mixed infections, the correlations of MICs of caspofungin to clinical outcomes are based on the MIC for the C. albicans isolate. The majority of patients (93%) with C. albicans infections had MICs of 0.25, 0.5, or 1.0 μg/ml, and no clear correlation between outcome and the MIC for C. albicans was identified across this range (success in 77%, 77%, and 83%, respectively). There were only seven isolates obtained from patients who did not also have a coinfection with C. albicans, and each had a favorable clinical outcome.
In 41 patients with unfavorable microbiological outcomes following caspofungin treatment, susceptibility testing was also performed on a subsequent Candida isolate collected from the esophagus. Comparisons of the MICs of these subsequent isolates to the original baseline isolates failed to demonstrate any instance where a ≥2-fold increase in MIC for caspofungin was noted for the subsequent isolate. In fact, the MIC of the subsequent isolate from one patient actually decreased by twofold dilutions relative to the baseline isolate (1.0 μg/ml to 0.25 μg/ml).
Invasive candidiasis. (i) MIC distribution.Susceptibility testing for caspofungin was performed on 231 unique baseline isolates from all patients enrolled in the two studies of invasive candidiasis. Of the 231 isolates, 114 were obtained from patients who were subsequently treated with caspofungin. The distributions of MIC results for caspofungin for isolates obtained from all patients and for isolates obtained from caspofungin-treated patients are similar (Fig. 3). The distribution of MIC results for caspofungin among these 114 isolates is generally consistent with the overall pattern from the esophageal studies (Fig. 1). Overall, MICs for caspofungin ranged from 0.06 to 8 μg/ml, with a majority (∼96%) of values between 0.125 and 2 μg/ml. In fact, the MIC50 and MIC90 for caspofungin across all Candida species were 0.5 and 2.0 μg/ml, respectively (Table 1).
(ii) Correlation of MIC to outcome.The correlation of caspofungin MICs to overall outcomes for the patients with invasive candidiasis is displayed for the MITT population and the EP population in Fig. 4A and B, respectively. Similar to what was found for esophageal candidiasis, there was no clear correlation between the MIC for caspofungin and the efficacy response seen in caspofungin-treated patients with invasive candidiasis. There was a greater proportion of favorable outcomes for patients with isolates for which MICs were higher (>2 μg/ml) than for patients with isolates for which MICs were lower (<1 μg/ml).
In the caspofungin-treated patients, a wide array of Candida species was isolated from the patients with invasive candidiasis. The most common species isolated was C. albicans (43 isolates), followed by C. tropicalis (23 isolates), C. parapsilosis (22 isolates), and C. glabrata (15 isolates). The correlations between caspofungin MICs and overall outcomes are shown for each of these species in Table 2. The correlation of MIC to overall outcome for other, less common Candida species, including C. krusei (five isolates), C. guilliermondii (four isolates), C. lipolytica (one isolate), and C. rugosa (one isolate), are grouped together in Table 2. No clear correlation between MIC and outcome for the specific Candida pathogen(s) was identified. Notably, similar trends were identified by looking at the relationship of the MIC for caspofungin to the microbiological response (data not shown).
In 20 patients with unfavorable microbiological outcomes following treatment with caspofungin, susceptibility testing was also performed on a subsequent Candida isolate collected from the site of invasive infection. Comparisons of the MICs of the paired isolates (original baseline isolate and subsequent isolate) from these specific patients failed to demonstrate any instance where a ≥2-fold increase in the MIC of caspofungin was noted for the subsequent isolate.
In this report, we present the susceptibility results for caspofungin and their correlation to outcomes for 746 clinical isolates of Candida spp. All yeast isolates were collected between 1997 and 2003 from patients with documented evidence of either esophageal or invasive candidiasis. These pretreatment isolates were uniformly tested in a single microbiological laboratory in an effort to ensure accurate identification and consistent MIC readings for the echinocandin. In our estimation, this review represents one of the largest evaluations of caspofungin susceptibility of contemporary yeast isolates using the method recently described by Odds and his colleagues (18). Importantly, it also signifies the first attempt to correlate the MIC for an echinocandin to clinical outcomes for patients with documented Candida infections. The entry criteria, outcome definitions, and primary evaluation time points were similar across the studies within each of the two indications (3, 15, 30-32), and, as a result, such correlations of susceptibility results to efficacy responses could be readily combined across all protocols.
This review highlights two interesting findings that warrant further discussion. First, the results demonstrate potent in vitro activity of caspofungin against a variety of strains of Candida. Across all Candida species, the MIC50 and MIC90 for caspofungin were 0.5 and 2 μg/ml, respectively (24, 25, 27, 28). The lowest MICs were noted for C. albicans, C. glabrata, and C. tropicalis, which accounted for over 85% of the baseline isolates from these patients. A trend towards higher MICs relative to those of the other species was noted for C. parapsilosis, C. krusei, and C. guilliermondii. The pattern of susceptibility results is consistent with other surveillance studies involving clinical isolates of Candida species (20-22). However, in these studies, the higher MICs did not equate to poorer efficacy responses in patients infected with these strains; in fact, clinical success following caspofungin therapy was seen in 77% of patients with invasive candidiasis resulting from any one of these three pathogens (73%, 100%, and 75% for C. parapsilosis, C. krusei, and C. guilliermondii, respectively). In comparison, favorable outcomes were noted for 75% of the patients with invasive candidiasis resulting from C. albicans, C. glabrata, or C. tropicalis (70%, 80%, and 83%, respectively).
Second, the data from these clinical trials fail to demonstrate a correlation between higher MICs for caspofungin and clinical or microbiological outcomes for patients treated with this echinocandin. Combining the results across the two disease states helps to better elucidate this finding. Among the 746 unique baseline isolates identified from the six studies of esophageal and invasive candidiasis, 406 identified from patients treated with caspofungin are available for MIC outcome assessments. The vast majority of these isolates (386 isolates; 95%) had MICs ranging between 0.25 and 2 μg/ml. Across this range, the MIC pattern was not related to outcome (MICs of 0.25, 0.5, 1, and 2 μg/ml were associated with success rates of 71%, 77%, 81%, and 91%, respectively). Additionally, all three isolates with caspofungin MICs of >2 μg/ml responded favorably to this antifungal. Taken together, a caspofungin success rate of 83% (149 of 178) was demonstrated for all isolates with MICs of >1 μg/ml of caspofungin.
The lack of correlation with higher MICs is not an unexpected finding, given previous experience with both antibacterial (10, 27, 28) and antifungal susceptibility testing (24, 25). The finding is likely a result of several factors. For one thing, antifungal susceptibility testing provides only a static assessment of the potential effect of an antimicrobial agent on a particular pathogen. The antifungal activity of caspofungin may indeed be augmented by a variety of pharmacological conditions, including the achieved pharmacokinetic concentration for the patient at the particular site of infection and the potentiated effect of serum or other compounds. In addition, host factors, such as the patient's underlying medical condition or immunological status, or specific medical practices may significantly impact the outcome for the patient, irrespective of the inherent antimicrobial effect described in the laboratory (24). In particular, the APACHE (acute physiology and chronic health evaluation) score and vascular catheter exchanges have repeatedly been shown to play a major role in the outcomes of patients in clinical trials of invasive candidiasis (15, 23, 26). Another reason for the lack of correlation between susceptibility results and outcomes may relate to the paucity of isolates included in these clinical trials with known resistance to echinocandin. Although isolates of Candida spp. with reduced susceptibility to caspofungin have been generated in the laboratory (7, 13, 19) and have been reported on rare occasions in the clinical arena (11; see also caspofungin acetate [CANCIDAS] U.S. product insert, 2004, Merck & Co., Inc.), the strains included in these studies were collected from patients receiving a finite course of therapy for a documented infection. Furthermore, most isolates were collected from patients enrolled prior to the licensure of marketed caspofungin (3, 15, 30-32). We purport that any assessments of potential clinical breakpoints for echinocandins based on susceptibility testing in the future will likely need to carefully incorporate the susceptibility patterns of Candida strains which have demonstrated acquired resistance to these agents.
In summary, our data provide additional confirmatory evidence regarding the in vitro activity of caspofungin against a variety of clinical stains of Candida species. The lack of a clear relationship between MICs for caspofungin and clinical outcomes for patients with esophageal candidiasis or invasive candidiasis prevents us from assigning an interpretative MIC breakpoint for caspofungin based solely on the results of these studies. Ongoing surveillance of the caspofungin susceptibility pattern of strains from current clinical trials and from marketed use may indeed identify a sufficient sample of isolates with reduced susceptibility to caspofungin, thereby ultimately assisting in the assessment of the clinical breakpoints for caspofungin. Until that time, caution should be routinely exercised regarding the use and interpretation of susceptibility testing for caspofungin in the clinical care of patients with Candida infections.
Merck Research Laboratories provided support.
Statement on potential conflicts of interest: all authors are employees of Merck Research Laboratories, Merck & Company, Inc.
- Received 12 April 2005.
- Returned for modification 16 May 2005.
- Accepted 28 June 2005.
- Copyright © 2005 American Society for Microbiology


text:
Whittaker vs Gastelum UFC Betting Tips 10-02-2019
February 04, 2019
The Ultimate Fighting Championship lands at Melbourne's Rod Laver Arena this Sunday, with 13 fights on the card. The main event sees Aussie Robert "The Reaper" Whittaker appear in front of his home crowd for the first time since being crowned undisputed UFC middleweight champion in 2017.
- Whittaker to win by KO/TKO @2.50 with Palmerbet T&C Apply Visit T&Cs Apply
- Either competitor to win by finish @1.50 with Unibet T&Cs apply Visit T&Cs Apply
Whittaker, Silva Among Big Names at UFC 234
Whittaker's opponent in the octagon will be American Kelvin Gastelum, who's ranked fourth in the middleweight rankings. Like Whittaker, Gastelum is a striker. Whittaker averages 4.82 significant strikes per minute, ahead of Gastelum's 3.86. However, Gastelum strikes with greater accuracy than Whittaker, enjoying a 43.69% to 40.72% advantage.
Before they step into the Octagon, step into the lives of the main and co-main before Saturday's event. #UFC234 Countdown starts NOW on @ESPN! pic.twitter.com/ICMlHSddae— UFC (@ufc) February 3, 2019
The co-main event is also a middleweight bout featuring rising star Israel Adesanya and former world champ Anderson Silva. Veteran UFC fans know Silva as the man who enjoyed the longest title reign in UFC history, from 2006 through to 2013. However, the 43-year-old Brazilian has slipped to 15th in the rankings. Adesanya, 14 years his junior, is unbeaten from 15 bouts.
Other Aussies on the main card include Nadia Kassem in the women's flyweight and Jimmy Crute in the light heavyweight.
Melbourne I'm coming #ufc234 #homesoil #Australia #ufc @ufc pic.twitter.com/4Aq1wx0xRp— Robert Whittaker (@robwhittakermma) November 14, 2018
UFC 234 Betting Odds
As you'd expect of the champion, Whittaker will go in as betting favourite. The interest for punters will be in the method of victory, given this bout pits striker against striker. PalmerBet is paying a generous 2.50 on Whittaker to win by KO/TKO, which has been his method of victory in 48% of his 21 UFC wins. Unibet is paying 1.50 for either competitor to win by finish. These are good odds given both men win by finish in roughly 70% of their wins.
As for Silva v Adesanya, bet365 is offering enticing 5.50 odds on Silva taking us back to yesteryear and defeating Adesanya. Neds is paying 1.67 for the fight to end with a KO/TKO, which is the method of victory in 87% of Adesanya's wins and 65% of Silva's wins.
Whittaker to win by KO/TKO @2.50 with PalmerBetVisit


text:
The Gift of Sight (with Vinesong)
November 12, 2018
'Open my eyes that I may see wonderful things...' (Psalm 119.18, NIV). One of the greatest gifts God has given us is the gift of sight. When Jesus saw the man born blind in John 9, He was moved with compassion. This man had never seen the blue sky or the beauty of flowers. His life was spent in darkness. But that day Jesus restored his sight.
'Happy Song' used by kind permission of www.vinesong.com


text:
It's been a while since I've had a giveaway, but the time has come again! I'll review the book and you can find the giveaway details at the bottom. What the book is about: This is a devotional the goes through conversations individuals had with Jesus throughout the book of Matthew. The author took the … Continue reading Book Review AND GIVEAWAY!!: Talking to Jesus by Jeannie Blackmer
Review and Giveaway: Loved Baby by Sarah Philpott, PhD
This week is a bit different - it's Loved Baby week around here. I have in my possession TWO copies of Loved Baby to give away. October is Infant and Pregnancy Loss Awareness Month, so this week I will be focusing on this book, talking about it, and giving you opportunities to enter to win … Continue reading Review and Giveaway: Loved Baby by Sarah Philpott, PhD


text:
Common Debunks 'Cruel Winter' Rumours
Published Jan 22, 2013Ever since Cruel Summer arrived last year, rumours have circulated that Kanye West and his G.O.O.D. Music crew were plotting a followup compilation called Cruel Winter. It turns out that all this speculation may have been for naught, since Common has claimed that the album doesn't exist.
Speaking with Vulture, the rapper said, "I don't think that's happening. It was more of a rumor — cats been creating, but everybody's been doing their solo album. So that's what that is."
This contradicts various reports that Cruel Winter is in the works; for example, John Legend told Rolling Stone that he had written some hooks for the album. That said, we're inclined to take Common at his word here. After all, if Cruel Winter were going to arrive in its titular season, it would need to come out within the next two months, which seems like an awfully tight timeline.
You might remember that Cruel Winter was previously teased with a trailer that turned out to be fake.
Cruel Summer was greeted with lukewarm reviews, so perhaps it's for the best that the talented folks involved with G.O.O.D. Music focus on their own music.


text:
Maymay Made It — MISITI Bar Magnets
42 Christmas Tags in 1 hour and 17 minutes
Posted by Tamatha Luehrs on
Today we get a jump on all those Christmas tags! Wow, Maymay made 42 in 1 hour and 17 minutes! How fast can you make them? Let's find out, gather up those supplies and create! Supplies used: Santa Baby Journaling cards Tag Punch Board Angel Punch Christmas Instawreath stamp set MISTI Versafine Black Onyx ink Purple Tape Pen Blades TH Shears Bar and Circle MISIT magnets Versafine Clair inks: green oasis, warm breeze, and acorn Lawn Fawn Trimming: gold Trio Cardstock paper: lunch bag Please remember to head on over to our Facebook group,...
- 0 comment
- Tags: Brutus Monroe Trio, Christmas Instawreath Stamp set, Lawn Fawn Hemp Cord, MISITI Bar Magnets, Misti, Pen blades, Purple Tape, Santa Baby Journaling cards, tag punch board, Tim Holtz Shears, Versafine black onyx ink, Versafine Clair inks
Vellum and Heat Embossed Balloons on a Card
Posted by Tamatha Luehrs on
What says happy and cheerful on a card? BALLOONS! Today Maymay uses our newest stamp set Party Balloons to make a spectacular special occasion card! They look like real balloons! So gather up those supplies and let's create! Supplies used: Party Balloons Stamp Set: https://bit.ly/2LgDIWN Misti Stamp Positioner: https://bit.ly/2J5HKR8 Bar Magnet: https://bit.ly/2HZtXf6 Versamark Ink: https://bit.ly/2J2qGzz Powder Tool: https://bit.ly/2FoFD8y Nuvo Embossing Powder: https://bit.ly/2HddfHg Marvy Heat Tool: https://bit.ly/2FpawJO Cutter Bee Scissors: https://bit.ly/2sdSTtA Art Glitter Glue: https://bit.ly/2sA2BoA Fine Metal Tip for Art Glitter Glue: https://bit.ly/2w0EfFV Foam Squares: https://bit.ly/2vLCkHj Versafine Onyx Black Ink: https://bit.ly/2xaBhPi Stamp Scrubber: https://bit.ly/2Jp9rI7 Squeaky Clean: https://bit.ly/2xa7oyD Fiskars Stamp Blocks: https://bit.ly/2JchnZJ Product Parade...
- 0 comment
- Tags: 3D foam squares, art glitter glue, Art Glitter Glue fine metal tip, Brutus Monroe Squeaky Clean, Cutter Bee Scissors, embossing powder tool, Fiskars Stamping Blocks, marvy heat tool, MISITI, MISITI Bar Magnets, Nuvo Embossing Powder, Party Balloon Stamp Set, stamp scrubber, verda, versamark ink


text: Let your style heat up while you watch the action on the ice with women's Mark Giordano Calgary Flames gear from NHL Shop! Build your wardrobe with all the right essentials, including women's Calgary Flames t-shirts, polos and dresses. Bundle up at the rink with Calgary Flames hoodies and jackets, as well as warm accessories like Calgary Flames knit hats and scarves. NHL Shop carries all the women's Calgary Flames face coverings you need, as well as Calgary Flames jewelry and bags to add some extra flair to your game day outfit. No matter how you choose to express your style and team spirit, NHL shop has the perfect officially licensed women's Calgary Flames gear for you!


text:
Sixteen Personality Factors™ AGE: 16-Adult This updated version measures normal human personality using personality structure discovered through factor analysis. It includes 16 primary factor scales and 5 global factor scales. Good for client enrichment, self-awareness, and personal growth. (IPAT) Interpretive Report: $49. Test Booklet: $8. Read More
Adolescent Personality Questionnaire AGE: 11-22 The 16PF Adolescent Personality Questionnaire (APQ) is a self-report personality inventory that was specifically developed and normed for adolescents. It elicits valuable information regarding the youth's personal style, problem-solving abilities, preferred work activities, and areas where the youth is having problems, making the APQ appropriate for screening and for introducing sensitive topics in a counseling situation. The test includes four sections: Your Personal Style (normal personality items) Problem Solving (a short measure of general reasoning ability) Work Activity Preferences (measures six career-interest variables), and Life's Difficulties (optional questions concerning matters of sex, aggression, significant low mood, low sense of self, etc.). The APQ is useful in situations where personality is relevant – educational adjustment, personal or social difficulty, and passage through one's developmental tasks. The Work Activity Preferences section is particularly helpful with career exploration. In addition, the normal personality section (Your Personal Style) and the Work Activity section help professionals adjust their approach to the characteristics of the young person. Two interpretive reports are available from this questionnaire – the APQ Guidance Report and the APQ Psychological Report. (IPAT) Guidance Report: $46. Psychological Report: $57. Test Booklet: $8. Guidance report includes the first three sections. […] Read More
Alcohol Use Inventory AGE: 16-Adult The Alcohol Use Inventory (AUI) provides a basis for describing different ways in which individuals use alcohol, the benefits they derive from such use, the negative consequences associated with its use, and the degree of concern individuals express about the use of alcohol and its consequences. How to Use This Test The AUI test can be used by psychologists, social workers, chemical dependency counselors, and physicians to help: Differentiate drinking styles and develop individual treatment plans Provide an objective assessment of alcohol-related problems Identify treatment-relevant classification of alcohol abusers based on DSM-IV® classifications Key Features The AUI test's multidimensional approach can help the substance-abuse professional tailor a treatment plan to a clients specific problems. The self-report format of the AUI test enables substance-abuse professionals to compare an individual's perceptions about his or her use of alcohol with the interviewer's perceptions and those of family members and others. Profile Report: $33 Interpretive Inpatient Report: $42 Interpretive Outpatient Report: $42 Test Booklet: $8 Read More
Brief Symptom Inventory (BSI®) AGE: 13 – Adult The efficient Brief Symptom Inventory (BSI) instrument provides patient-reported data to help support clinical decision-making at intake and during the course of treatment in multiple settings. Psychologists, psychiatrists, physicians, nurses, and other healthcare professionals can use the BSI instrument to help: Assess patients at intake for psychological problems Objectively support care management decisions Measure patient progress during and after treatment to monitor change Provide outcomes measurement for treatment programs and providers through aggregated patient information Key Features The BSI test is brief and requires only 8-10 minutes to complete, making it well-suited for repeated administrations over time to evaluate patient progress. The BSI instrument provides an overview of a patient's symptoms and their intensity at a specific point in time. The Global Severity Index (GSI) is designed to help quantify a patient's severity-of-illness and provides a single composite score for measuring the outcome of a treatment program based on reducing symptom severity. The reliability, validity, and utility of the BSI instrument have been tested in more than 400 research studies. Interpretive Report: $36. Profile Report: $23. Answer Sheet: $0. Read More
Cattell Comprehensive Personality Interpretation AGE: 16-Adult The CCPI provides a thorough, in-depth profile of the individual's normal personality to help you gain an integrated understanding of the whole person from the start, including insights as to how the individual will present in therapy. Designed for use in a wide range of clinical and counseling applications, the CCPI is useful wherever a comprehensive understanding of the individual is needed since it addresses functioning in a wide variety of areas – from self-esteem, empathy, and interpersonal relationships, to values, information processing style, and achievement orientation. (IPAT) Interpretive Report: $57. 16PF Test Booklet: $8. Read More
Eating Disorder Inventory AGE: 13-Adult This improved self-report inventory is designed to assess a broad range of meaningful psychological features common in anorexia nervosa and bulimia nervosa. Three new subscales have been added as well as updated norms and reliability and validity data. (PAR) Report: $44. Test Booklet: $5. Read More
Inventory of Suicide Orientation AGE: 13-18 The Inventory of Suicide Orientation-30 (ISO-30) assessment provides an overall suicide risk classification based on measurements of hopelessness and suicide ideation. How to Use This Test Appropriate for use by psychologists, licensed social workers, and licensed counselors in outpatient and inpatient mental health facilities, juvenile justice evaluations, and school settings. The ISO-30 assessment can help: Identify adolescents at risk for attempting suicide Facilitating objective communication with the family, other counseling professionals, and insurance providers Measure abatement of suicidal symptoms after an adolescent has been hospitalized Key Features The test's brevity helps minimize test-taking resistance. Results help alert psychologists and counselors to the early signs of an adolescent's suicidal tendencies, providing the opportunity for earlier intervention. The test's adolescent normative base allows for more relevant comparisons than tests with norms that include adults. Scales Helps measure a broadly-defined construct of hopelessness using the total score from the 30 items. Suicide ideation is assessed by 6 critical items within those 30 items. The total score and the critical item score help determine overall suicide risk classification (high, moderate, low). Psychometric Information Clinical data were collected on 366 adolescents ages 12 to 18. A student sample […] Read More
Millon™ Pre-Adolescent Clinical Inventory AGE: 9-12 Every child deserves to enjoy youth to the fullest. But for some young people, psychological problems can stand in the way—and these difficulties may take root long before the "troubled teens." As a professional who works with children daily, you know first-hand the challenges some preteens face. And, we know the challenges you may face in pinpointing the source of pre-adolescent issues. Now, there's a comprehensive tool specifically designed to help you quickly and accurately identify psychological problems in children ages 9–12: the Millon®; Pre-Adolescent Clinical Inventory (M-PACI®). Unlike instruments that focus on a single clinical area such as anxiety or depression, the M-PACI assessment provides an integrated view that synthesizes the child's emerging personality styles and clinical syndromes, helping clinicians detect early signs of Axis I and Axis II disorders. Effective and efficient, the M-PACI can help you arrange early intervention on difficulties that may keep students from making the most of their preteen years—and these, if left undetected, can lead to bigger heartaches down the road. How to Use This Test The M-PACI is used for pre-adolescent assessment in outpatient, inpatient, day treatment, and residential treatment settings. Psychologists, psychiatrists, school psychologists, […] Read More
Millon™ Adolescent Clinical Inventory AGE: 13-19 New Grossman Facet Scales zero in on critical issues. Unlike many other instruments developed for adults and adapted for adolescents, the MACI assessment was specifically created to address the unique concerns, pressures and situations facing teens. This dedicated tool, recently enhanced by the addition of Grossman Facet Scales, helps assess personality patterns as well as self-reported concerns and clinical symptoms. Brief and easy to administer, the MACI can assist practitioners in constructing treatment plans customized to individual needs and help them guide troubled youth toward healthier, more authentic lives. How to Use This Test The MACI is well-suited for use in all teen treatment settings, including outpatient, inpatient, day treatment and residential treatment programs. Psychologists, psychiatrists, school psychologists, juvenile justice professionals and other mental health professionals find this versatile instrument essential in helping to: Conduct detailed evaluations to confirm diagnostic hypotheses Create individualized treatment plans Measure progress before, during and after treatment Key Features To help you formulate more precise treatment plans, the new Grossman Facet Scales identify personality processes (e.g., self-image, mood temperament) that underlie overall scale elevations on the Personality Pattern scales. Each personality scale now has three facet scales, for […] Read More
Millon™ Adolescent Personality Inventory AGE: 13-18 For use with both typical and troubled teens. The Millon Adolescent Personality Inventory (MAPI) is normed on both normal adolescents and adolescent patients. The inventory outlines three distinct scale dimensions: personality styles, expressed concerns, and behavioral patterns. How to Use This Test The MAPI can be used for diagnosis and treatment planning in clinical, correctional, and educational settings by psychologists, psychiatrists, and school counselors, as well as other mental health and guidance professionals. Key Features Most adolescents can complete the test in 20–30 minutes, helping to reduce resistance to test-taking. Scales help evaluate adolescent expressed concerns, personality styles, and coping patterns to help select the best approach to treatment and identify behavior patterns and issue that may need further exploration during therapy. Interpretive Report: $55. Test Booklet: $7. Read More


text:
Bernie walked up with a coffee this morning looking at the rig on Island Dancer..
He smiled and said… WOW
Bernie is the head of stepping masts (installing)
I somehow found a smile, wondering what I was getting myself into…
This boat is SMALL in the caribbean… whats the big deal.. lets go!
Bernie: "There's no way my rig can lift that mast…"
Timbo: "Really.. so Bernie… what are we using then? " – There was NO way the mast going to be horizontal on the deck after today…. I love putting confidence back into the experts… he'll figure out a way!
But again… this is only a hollow mast.. couple farm boys could put it in… trust me I have stories!
There was a bit of a Spectacle in Oswago… at one point Robin counted more than 15 watching just in the immediate area of the boat…
Everything went smooth smooth smooth.. and we now have two masts back in the vertical position…
We stopped working at 10pm (Kozyboat crew).. its a ton of work getting all the gear back together… but were ready to hit the sea.. hummm I mean LAKE… tomorrow!!!
Very great people here.. (I must have met some non-great people, somewhere, sometime on this trip??)
You will see from the pictures the number of people we had helping.. That with crane, gin pole, and paid talent… what the heck is this going to cost??
Turned out to be a little over $300… I was thinking more like $500-700… we had the crane and operator tied up all afternoon.. and a lot of marina people!!!
I really need to buy a "I Love NY" T-Shirt !!!!
The 30 locks have certainly improved Timbo's docking skills…. This boat is turning into a skate board in a parking lot…
The marina people came up to me and said "Gee.. We hardly ever see anyone driving a SAILBOAT dock without hitting something" ha!!!
I can't wait to come into Bridgeview in Sarnia and smash into 3 boats my first time!!!